X Chromosome Inactivation

Download PDF

Recent Publications on X Chromosome Inactivation:
Lack of association between skewing of X-chromosome inactivation in blood cells and colorectal cancer. no abstract....	17th July, 2008	Faculty Division Rikshospitalet, University of Oslo, Oslo - Norway.	Int J Biol Markers. 2008 April - June;23(2):127-128.
Epigenetic analysis of the Critical Region I for Premature Ovarian Failure (POF): demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome. X chromosome rearrangements defined a critical region for premature...	17th July, 2008	DIBIT-San Raffaele Scientific Institute, Milano, Italy.	J Med Genet. 2008 Jul 15;. DOI Direct Link
Xist RNA is confined to the nuclear territory of the silenced X chromosome throughout the cell cycle. In mammalian female cells one X chromosome is inactivated, to prevent a...	16th July, 2008	Department of Cell Biology, and Department of Reproduction and	Mol Cell Biol. 2008 Jul 14;. DOI Direct Link
Many different tumor types have polyclonal tumor origin: Evidence and implications. Few ideas have gained such strong acceptance in the scientific community...	11th July, 2008	Division of Genetic and Reproductive Toxicology, National Center for	Mutat Res. 2008 Jul 7;. DOI Direct Link
Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes. BACKGROUND Human embryonic stem cell (hESC) lines derived from poor...	10th July, 2008	Institute of Gynecology and Obstetrics, The Third Affiliated Hospital of	Hum Reprod. 2008 Jul 8;. DOI Direct Link
→View more research publications.

X Chromosome Inactivation Clinical Trials:
X-Chromosome Inactivation Status and Premature Ovarian Failure	Premature Ovarian Failure

X Chromosome Inactivation Patents:
US Patent No.	Title
6326483	Compositions and methods based upon the tuberous sclerosis-1 (TSC1) gene and gene product
6709817	Method of screening Rett syndrome by detecting a mutation in MECP2
6709818	Methods of diagnosing and treating hepatic cell proliferative disorders
6756200	Aberrantly methylated genes as markers of breast malignancy
6773897	Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for X Chromosome Inactivation scientists - we have details of around 163 individuals working on X Chromosome Inactivation .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.